A Phase IV, Open Label, Study Evaluating the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab and CHP (R-CHP) in Previously Untreated Adult Patients With Diffuse Large B-Cell Lymphoma (DLBCL) – RGCI, DELHI
A Phase IV, Open Label, Study Evaluating the Safety and Efficacy of Polatuzumab Vedotin in Combination With Rituximab and CHP (R-CHP) in Previously Untreated Adult Patients With Diffuse Large B-Cell Lymphoma (DLBCL) – RGCI, DELHI